COT-13 Current situation and problems of cancer genomic profiling test in Kyoto University Hospital

Objective: Kyoto University Hospital has introduced the cancer genomic profiling tests, Oncoprime in 2015, Guardant360 in 2018, which are not under insurance coverage, FoundationOne CDx(F1CDx) and OncoGuide NCC Oncopanel system(NCC OP) in 2019, which received approval for insurance coverage for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakawa, Yoshiki, Suga, Junko, Terada, Yukinori, Nakajima, Kohei, Tanji, Masahiro, Mineharu, Yohei, Muto, Manabu, Miyamoto, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699132/
http://dx.doi.org/10.1093/noajnl/vdaa143.099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699132/
http://dx.doi.org/10.1093/noajnl/vdaa143.099

Ejemplares similares